Login to Your Account



Search

Search results

Pharma: clinic roundup

Pfizer Inc ., of New York, reported top-line results from a phase IIIB study evaluating the 24-month efficacy of Genotropin (somatropin) on the height in small-for-gestational-age children 24-30 months old. (BioWorld-Today-2014-03-27) ...

BioWorld Today - Staff - 2014-03-27 00:00 - 0 comments - 0 attachments

Clinic Roundup

• Ovascience Inc. , of Cambridge, Mass., suspended enrollment of a trial with Augment, its candidate designed to improve egg quality and increase the success of in vitro fertilization, because the FDA questioned the status of the product as a human c ...

BioWorld Today - Staff - 2013-09-12 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Pfizer Inc. , of New York, reported that PROFILE 1014, a phase III study testing anaplastic lymphoma kinase (ALK) inhibitor Xalkori (crizotinib) met its primary objective of significantly prolonging progression-free survival in previously untreated p ...

BioWorld Today - Staff - 2014-03-26 00:00 - 0 comments - 0 attachments

Clinic roundup

Catalyst Pharmaceutical Partners Inc. , of Coral Gables, Fla., said the independent data monitoring committee recommended that the ongoing pivotal phase III trial of Firdapse for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) continue as p ...

BioWorld Today - Staff - 2014-03-26 00:00 - 0 comments - 0 attachments

Clinic roundup

Ariad Pharmaceuticals Inc. , of Cambridge, Mass., said it started a pivotal phase II study of AP26113 in patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC) who previously were treated with Xalkori (crizotinib, Pfizer Inc. ...

BioWorld Today - Staff - 2014-03-25 00:00 - 0 comments - 0 attachments

Clinic roundup

Cellceutix Corp. , of Beverly, Mass., said the FDA’s 30-day waiting period pertaining to the investigational new drug application for Prurisol has passed, and the company is moving toward starting clinical trials of the small-molecule drug in psorias ...

BioWorld Today - Staff - 2014-03-24 00:00 - 0 comments - 0 attachments

Clinic Roundup

• Inovio Pharmaceuticals Inc. , of Blue Bell, Pa., said the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in an 18-patient Phase I trial in chronically hepatitis C virus-infec ...

BioWorld Today - Staff - 2013-10-22 00:00 - 0 comments - 0 attachments

Clinic roundup

Synta Pharmaceuticals Corp. , of Lexington, Mass., said interim results from the ENCHANT-1 trial, a single-arm multicenter phase II proof-of-concept study designed to evaluate ganetespib, administered as a monotherapy for the treatment of metastatic ...

BioWorld Today - Staff - 2014-03-21 00:00 - 0 comments - 0 attachments

Pharma: clinic roundup

Abbvie Inc. , of North Chicago, Ill., said a pivotal phase III trial that will evaluate the use of Humira (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, has been initiated. ...

BioWorld Today - Staff - 2014-03-21 00:00 - 0 comments - 0 attachments

Clinic Roundup

Biogen Idec Inc. , of Weston, Mass., and Swedish Orphan Biovitrum AB , of Stockholm, Sweden, disclosed positive results from A-LONG, a Phase III trial that evaluated a long-lasting clotting factor candidate in people with hemophilia A. (B ...

BioWorld Today - Staff - 2013-12-06 01:00 - 0 comments - 0 attachments